Angiotensin-(1-7) in hypertension

被引:8
作者
Chappell, MC [1 ]
Ferrario, CM [1 ]
机构
[1] Wake Forest Univ, Bowman Gray Sch Med, Hypertens & Vasc Dis Ctr, Winston Salem, NC 27157 USA
关键词
D O I
10.1097/00041552-199903000-00013
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Recent evidence suggests that angiotensin-(1-7) is a bioactive component of the renin-angiotensin system that may oppose or, in certain situations contribute to the actions of Ang II. Ang-(1-7) can be directly formed from Ang I bypassing the requisite production of Ang II. In contrast to forming Ang II, angiotensin-converting enzyme hydrolyses Ang-(1-7) to inactive fragments. Angiotensin-converting enzyme inhibitors substantially augment circulating levels of Ang-(1-7) and increase the peptide's half-life six-fold. Thus, angiotensin-converting enzyme may constitute an important regulatory point to balance the actions of Ang II, Ang-(1-7) and bradykinin. Indeed, Ang-(1-7) can potentiate the actions of bradykinin through a receptor-mediated site and a direct interaction with angiotensin-converting enzyme. We summarize recent studies that reveal depressor, vasodilator, and antihypertensive actions of Ang-(1-7) thus providing evidence that Ang-(1-7) is the antihypertensive peptide of the renin-angiotensin system. Curr Opin Nephrol Hypertens 8:231-235. (C) 1999 Lippincott Williams & Wilkins.
引用
收藏
页码:231 / 235
页数:5
相关论文
共 37 条
  • [11] Angiotensin-(1-7) inhibits vascular smooth muscle cell growth
    Freeman, EJ
    Chisolm, GM
    Ferrario, CM
    Tallant, EA
    [J]. HYPERTENSION, 1996, 28 (01) : 104 - 108
  • [12] GARCIA NH, 1994, J AM SOC NEPHROL, V5, P1133
  • [13] AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism
    Gohlke, P
    Pees, C
    Unger, T
    [J]. HYPERTENSION, 1998, 31 (01) : 349 - 355
  • [14] Gorelik G, 1998, J PHARMACOL EXP THER, V286, P403
  • [15] Renal actions of angiotensin-(1-7): In vivo and in vitro studies
    Handa, RK
    Ferrario, CM
    Strandhoy, JW
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1996, 270 (01) : F141 - F147
  • [16] ACE inhibitor potentiation of bradykinin-induced venoconstriction
    Hecker, M
    Blaukat, A
    Bara, AT
    MullerEsterl, W
    Busse, R
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (07) : 1475 - 1481
  • [17] HEYNE N, 1995, KIDNEY INT, V47, P975
  • [18] ASSOCIATION BETWEEN THE NATRIURETIC ACTION OF ANGIOTENSIN-(1-7) AND SELECTIVE STIMULATION OF RENAL PROSTAGLANDIN I-2 RELEASE
    HILCHEY, SD
    BELLQUILLEY, CP
    [J]. HYPERTENSION, 1995, 25 (06) : 1238 - 1244
  • [19] ANGIOTENSIN ACTIONS IN THE KIDNEY - RENEWED INSIGHT INTO THE OLD HORMONE
    ICHIKAWA, I
    HARRIS, RC
    [J]. KIDNEY INTERNATIONAL, 1991, 40 (04) : 583 - 596
  • [20] Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan
    Iyer, SN
    Chappell, MC
    Averill, DB
    Diz, DI
    Ferrario, CM
    [J]. HYPERTENSION, 1998, 31 (02) : 699 - 705